Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.75 HKD | -5.74% | +1.23% | -23.36% |
04-26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Neutral |
Resistance | 32.75 | 47.50 | 47.40 |
Spread/Res. | -12.37% | -39.58% | -39.45% |
Spread/Supp. | +11.89% | +88.57% | +75.43% |
Support | 25.65 | 15.22 | 16.36 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 9995 Stock
- Charts RemeGen Co., Ltd.